FDA advisory panel rejects widespread Pfizer booster shots

<p><p>WASHINGTON — An influential federal advisory panel has soundly rejected a plan to offer Pfizer booster shots against COVID-19 to most Americans.</p></p><p><p>The vote Friday, 16-2, was a blow to the Biden administration’s effort to shore up people’s protection against the virus amid the highly contagious delta variant.</p></p><p><p>Over several hours of discussion, members of the Food and Drug Administration panel of outside experts voiced frustration that Pfizer had provided little data on safety of extra doses.</p></p><p><p>And they complained that data provided by Israeli researchers about their booster campaign might not be suitable for predicting the U.S. experience.</p></p>